Past, present, and future - MBSW Online

More documents

Recommendations

Info

• Follow the approach recommended in the SPERTCrowe et al (2009)• Use multiple approaches (eg, fixed effects vs randomeffects)• Bayesian methods• Multi-item Gamma Poisson Shrinker• Three level hierarchicalmixture modelSPERT: Safety Planning Evaluationand Reporting TeamMuncie, IN May 25, 2011 C. Gassmann-Mayer Johnson & Johnson32
• Establish criteria for studies to include• Placebo-controlled studies only• Across indications and by indication• Consider separate meta-analysesfor considerable differences in duration• Routinely use Forest PlotsMuncie, IN May 25, 2011 C. Gassmann-Mayer Johnson & Johnson33
Page 1 and 2: Past, present, and future34 th Annu
Page 3 and 4: • Research question in clinical t
Page 5 and 6: Is suicidalitythe right term ?Munci
Page 7 and 8: Where we wereWhere we areWhere we a
Page 9 and 10: • 2008- 2009• PhRMA* Working gr
Page 11 and 12: • September 2010• FDA Draft Cli
Page 13 and 14: C-CASA=classification system1. Comp
Page 15 and 16: • Since 2009The statistical sub t
Page 17 and 18: • Contribute the scientific dialo
Page 19 and 20: Collection of suicide-related dataI
Page 21 and 22: www.cssrs.columbia.edu/scales_cssrs
Page 23 and 24: • Suicide-related endpoints• Tr
Page 25 and 26: • Definition of treatment-emergen
Page 27 and 28: Recent HistoryAll prior History =Li
Page 29 and 30: • Suicidal behaviors have no “n
Page 31: • Time-to-event analyses• Time-
Page 35 and 36: • No uniformly “best” method
Page 37 and 38: Muncie, IN May 25, 2011 C. Gassmann
Page 39 and 40: • Beck, A.T., Kovacs, M. & Weissm
Page 41 and 42: • Berlin and Colditz (1999). The
Page 43 and 44: • Pintilie, M. Competing risks: a

Past, present, and future - MBSW Online

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?